ClinicalTrials.Veeva

Menu

Outcome of Different IOLs in Patients With and Without Uveitis

V

Vastra Gotaland Region

Status

Completed

Conditions

Inflammation
Uveitis
Cataract
Posterior Capsule Opacification

Treatments

Device: Hydrophobic IOL: Vivinex (HOYA)
Device: Hydrophilic IOL: INCISE (Bausch+Lomb)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Cataract, is a clouding of the lens in the eye gradually leading to reduction of the visual acuity. In most cases it can be managed with surgery, removing the own lens and replacing it with an artificial lens, intraocular lens (IOL). These lenses are made in different materials with different properties.

Uveitis refers to an inflammation in the iris, ciliary body and choroid. Patients with this disease have an increased risk of developing cataract due to the inflammation itself and treatment with steroids. They also have an increased risk of complications during surgery and postoperatively. In this group the selection of IOL might be of greater importance.

The aim of this prospective randomized controlled study is to compare the outcome of hydrophobic and hydrophilic intraocular lenses in patients with and without uveitis

Enrollment

56 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cataract requiring surgery
  • Ability to understand and sign consent form

Exclusion criteria

  • Extensive corneal scarring
  • Other eye surgery less than 3 months before inclusion
  • Unregulated glaucoma
  • Active uveitis (increased inflammation and treatment less than 3 months before inclusion)
  • Intraoperative complications (capsular tear or vitreous loss)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

56 participants in 2 patient groups

Hydrophobic IOL: Vivinex (HOYA)
Other group
Description:
Intraocular lens with hydrophobic properties: Vivinex (HOYA).
Treatment:
Device: Hydrophobic IOL: Vivinex (HOYA)
Hydrophilic IOL: INCISE (Bausch+Lomb)
Other group
Description:
Intraocular lens with hydrophilic properties: INCISE (Bausch+Lomb).
Treatment:
Device: Hydrophilic IOL: INCISE (Bausch+Lomb)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems